bevacizumab,panitumumab
roche,amgen
['rectal', 'colorectal', 'bevacizumab', 'panitumumab']
trial just published to coincide with #aacr23: panitumumab vs bevacizumab added to standard first-line chemotherapy and overall survival among patients with ras wild-type, left-sided metastatic colorectal cancer, from , free to read online 
Home of @JAMA_Current, @JAMANetworkOpen, @JAMAHealthForum, & 10 specialty journals that publish science and opinion shaping #medicine today and into the future.